Report Detail

Pharmaceuticals & HealthcareMyocarditis - Pipeline Review, H2 2018

  • RnM2315576
  • |
  • 7 August, 2018
  • |
  • Global
  • |
  • 39 pages
  • |
  • Global Markets Direct
  • |
  • Pharmaceuticals & Healthcare

Myocarditis - Pipeline Review, H2 2018

Table of Contents

    List of Tables

      List of Figures


          Global Markets Direct Report Coverage

            Myocarditis - Overview

              Myocarditis - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Pipeline by Universities/Institutes

                      Products under Development by Companies

                        Products under Development by Universities/Institutes

                          Myocarditis - Therapeutics Assessment

                            Assessment by Target

                              Assessment by Mechanism of Action

                                Assessment by Route of Administration

                                  Assessment by Molecule Type

                                    Myocarditis - Companies Involved in Therapeutics Development

                                      Apitope International NV

                                        CEL-SCI Corp

                                          Evotec AG

                                            Swedish Orphan Biovitrum AB

                                              Myocarditis - Drug Profiles

                                                anakinra - Drug Profile

                                                  Product Description

                                                    Mechanism Of Action

                                                      R&D Progress

                                                        ATX-MYO - Drug Profile

                                                          Product Description

                                                            Mechanism Of Action

                                                              R&D Progress

                                                                CEL-1000 - Drug Profile

                                                                  Product Description

                                                                    Mechanism Of Action

                                                                      R&D Progress

                                                                        OBR-5340 - Drug Profile

                                                                          Product Description

                                                                            Mechanism Of Action

                                                                              R&D Progress

                                                                                Recombinant Peptides for Myocardial Infarction and Myocarditis - Drug Profile

                                                                                  Product Description

                                                                                    Mechanism Of Action

                                                                                      R&D Progress

                                                                                        Small Molecule to Inhibit Coxsackievirus B3 3C Protease for Myocarditis - Drug Profile

                                                                                          Product Description

                                                                                            Mechanism Of Action

                                                                                              R&D Progress

                                                                                                Myocarditis - Dormant Projects

                                                                                                  Myocarditis - Product Development Milestones

                                                                                                    Featured News & Press Releases

                                                                                                      Dec 11, 2017: Evotec's Academic Bridge LAB282 with Oxford University celebrating one year of impact

                                                                                                        Nov 10, 2016: Evotec and Oxford create novel Partnership called 'LAB282'




                                                                                                                Secondary Research

                                                                                                                  Primary Research

                                                                                                                    Expert Panel Validation

                                                                                                                      Contact Us


                                                                                                                        Myocarditis - Pipeline Review, H2 2018


                                                                                                                        Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis - Pipeline Review, H2 2018, provides an overview of the Myocarditis (Cardiovascular) pipeline landscape.

                                                                                                                        Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by viral, bacterial, or fungal infections that reach the heart. Symptoms include chest pain, rapid or abnormal heartbeat, shortness of breath, at rest or during physical activity, fluid retention with swelling of legs, ankles and feet and fatigue. Treatment includes antibiotics, anti-inflammatory medicines to reduce swelling and diuretics to remove excess water from the body.

                                                                                                                        Report Highlights

                                                                                                                        Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Myocarditis - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Myocarditis (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

                                                                                                                        The Myocarditis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocarditis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Preclinical and Discovery stages are 1, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.

                                                                                                                        Myocarditis (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

                                                                                                                        Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


                                                                                                                        - The pipeline guide provides a snapshot of the global therapeutic landscape of Myocarditis (Cardiovascular).
                                                                                                                        - The pipeline guide reviews pipeline therapeutics for Myocarditis (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
                                                                                                                        - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
                                                                                                                        - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
                                                                                                                        - The pipeline guide reviews key companies involved in Myocarditis (Cardiovascular) therapeutics and enlists all their major and minor projects.
                                                                                                                        - The pipeline guide evaluates Myocarditis (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
                                                                                                                        - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
                                                                                                                        - The pipeline guide reviews latest news related to pipeline therapeutics for Myocarditis (Cardiovascular)

                                                                                                                        Reasons to buy

                                                                                                                        - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
                                                                                                                        - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
                                                                                                                        - Find and recognize significant and varied types of therapeutics under development for Myocarditis (Cardiovascular).
                                                                                                                        - Classify potential new clients or partners in the target demographic.
                                                                                                                        - Develop tactical initiatives by understanding the focus areas of leading companies.
                                                                                                                        - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
                                                                                                                        - Formulate corrective measures for pipeline projects by understanding Myocarditis (Cardiovascular) pipeline depth and focus of Indication therapeutics.
                                                                                                                        - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
                                                                                                                        - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

                                                                                                                        Get latest Market Research Reports on Myocarditis. Industry analysis & Market Report on Myocarditis is a syndicated market report, published as Myocarditis - Pipeline Review, H2 2018. It is complete Research Study and Industry Analysis of Myocarditis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                                                        REPORT YOU MIGHT BE INTERESTED

                                                                                                                        Purchase this Report

                                                                                                                        Add To Cart Credit card Logo

                                                                                                                        Related Reports

                                                                                                                        Reason to Buy

                                                                                                                        Request for Sample of this report